Vaccine effectiveness against influenza hospitalisation in adults during the 2022/2023 mixed season of influenza A(H1N1)pdm09, A(H3N2) and B circulation, Europe: VEBIS SARI VE hospital network.

MLA

Rose, Angela M. C., et al. “Vaccine Effectiveness against Influenza Hospitalisation in Adults during the 2022/2023 Mixed Season of Influenza A(H1N1)Pdm09, A(H3N2) and B Circulation, Europe: VEBIS SARI VE Hospital Network.” Influenza & Other Respiratory Viruses, vol. 18, no. 2, Feb. 2024, pp. 1–9. EBSCOhost, https://doi.org/10.1111/irv.13255.

APA

Rose, A. M. C., Pozo, F., Martínez, B. I., Mazagatos, C., Bossuyt, N., Cauchi, J. P., Petrović, G., Loghin, I. I., Vaikutyte, R., Buda, S., Machado, A., Duffy, R., Oroszi, B., Howard, J., Echeverria, A., Andreu, C., Barbezange, C., Džiugytė, A., Nonković, D., & Popescu, C. (2024). Vaccine effectiveness against influenza hospitalisation in adults during the 2022/2023 mixed season of influenza A(H1N1)pdm09, A(H3N2) and B circulation, Europe: VEBIS SARI VE hospital network. Influenza & Other Respiratory Viruses, 18(2), 1–9. https://doi.org/10.1111/irv.13255

Chicago

Rose, Angela M. C., Francisco Pozo, Baz, Iván Martínez, Clara Mazagatos, Nathalie Bossuyt, John Paul Cauchi, Goranka Petrović, et al. 2024. “Vaccine Effectiveness against Influenza Hospitalisation in Adults during the 2022/2023 Mixed Season of Influenza A(H1N1)Pdm09, A(H3N2) and B Circulation, Europe: VEBIS SARI VE Hospital Network.” Influenza & Other Respiratory Viruses 18 (2): 1–9. doi:10.1111/irv.13255.